selected publications
-
Video-assisted thoracic surgery in the primary management of advanced ovarian carcinoma with moderate to large pleural effusions: A Memorial Sloan Kettering Cancer Center Team Ovary Study.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 5 -
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 16 -
Practical guidelines for triage to neoadjuvant chemotherapy in advanced ovarian cancer: Big risk, big reward…or too much risk?.
Gynecologic oncology.
2020
Editorial Article
GET IT
Times cited: 2 -
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery.
Journal of gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 17 -
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 44 - A Thoughtful Pause for Sparing Oophorectomy. Urology. 2019 Letter GET IT
-
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer.
Gynecologic oncology.
2018
Academic Article
GET IT
Times cited: 13 -
Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer.
Gynecologic oncology.
2018
Academic Article
GET IT
Times cited: 16 -
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?.
Gynecologic oncology.
2018
Academic Article
GET IT
Times cited: 50 -
Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center.
Gynecologic oncology.
2018
Academic Article
GET IT
Times cited: 9 -
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Gynecologic oncology.
2017
Academic Article
GET IT
Times cited: 32 -
Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery.
Gynecologic oncology.
2017
Academic Article
GET IT
Times cited: 24 -
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2017
Academic Article
GET IT
Times cited: 37 -
Risk-reducing salpingectomy: Let us be opportunistic.
Cancer.
2017
Review
GET IT
Times cited: 22 -
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?.
Gynecologic oncology.
2017
Academic Article
GET IT
Times cited: 54 -
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Gynecologic oncology.
2017
Academic Article
GET IT
Times cited: 87 -
"Little Big Things": A Qualitative Study of Ovarian Cancer Survivors and Their Experiences With the Health Care System.
Journal of oncology practice.
2016
Academic Article
GET IT
Times cited: 13 -
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 11 - Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]. Gynecologic oncology. 2016 Academic Article GET IT
-
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 35 -
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 3 -
Is It Time to Centralize Ovarian Cancer Care in the United States?.
Annals of surgical oncology.
2015
Review
GET IT
Times cited: 43 -
Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance.
American journal of obstetrics and gynecology.
2015
Academic Article
GET IT
Times cited: 9 -
Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD).
Gynecologic oncology.
2015
Academic Article
GET IT
Times cited: 15 -
Surgical cytoreduction for disseminated benign disease after open power uterine morcellation.
2015
GET IT
Times cited: 12 -
A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.
Gynecologic oncology.
2014
Academic Article
GET IT
Times cited: 113